Mikhail V. Mironchenkov
Mikhail V. Mironchenkov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Tatyana V. Gavrilova
Academician E.A. Vagner Perm State Medical University
3 shared publications - Artem O. Charushin
Wagner Perm State Medical University
2 shared publications - Irina P. Charushina
Wagner Perm State Medical University
2 shared publications - Sofya N. Khostelidi
Mechnikov North-Western State Medical University
2 shared publications - A. G. Grinev
Sverdlovsk Regional Clinical Hospital No. 1
1 shared publication - Ekaterina S. Mironchenkova
Perm State Medical University
1 shared publication
Latest Publications
- 30 June 2026
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 22 (2)
Endophthalmitis caused by hyalohyphomycetes in a patient with type 2 diabetes mellitus (clinical case)
A clinical case of postoperative endophthalmitis caused by hyalohyphomycetes in a 75-year-old patient with type 2 diabetes mellitus and chronic kidney disease is presented. The disease developed 10 days after routine cataract phacoemulsifcation with intraocular lens implantation and was accompanied by severe infammation that was resistant to antibiotic therapy and repeated vitreoretinal interventions. Progression of the process to panophthalmitis required enucleation of the eyeball. The etiology of the identifed disease (septated hyphae and conidial structures characteristic of hyalohyphomycetes) was confrmed by the review of histological preparations in the mycological reference center.
- 30 June 2026
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 22 (2)
Endophthalmitis caused by hyalohyphomycetes in a patient with type 2 diabetes mellitus (clinical case)
A clinical case of postoperative endophthalmitis caused by hyalohyphomycetes in a 75-year-old patient with type 2 diabetes mellitus and chronic kidney disease is presented. The disease developed 10 days after routine cataract phacoemulsifcation with intraocular lens implantation and was accompanied by severe infammation that was resistant to antibiotic therapy and repeated vitreoretinal interventions. Progression of the process to panophthalmitis required enucleation of the eyeball. The etiology of the identifed disease (septated hyphae and conidial structures characteristic of hyalohyphomycetes) was confrmed by the review of histological preparations in the mycological reference center.
- Open Access
- 1 October 2025
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 22 (3) , 577-581
Surgical Treatment of Primary Open-angle Glaucoma Using Micropulse Laser Exposure
Purpose. Analysis of the results of micropulse transscleral cyclophotocoagulation in patients with primary open-angle glaucoma. Materiales and methods. The study analyzed medical records of 91 patients with primary open-angle glaucoma (POAG) stages II–IV in 93 eyes. Of these, 42 (46 %) were men and 49 (54 %) were women. The average age of the study participants was 70 ± 15 years. Stage II of the disease occurred in 28 % of cases, stage III — in 59 %, and stage IV — in 13 %. The initial intraocular pressure (IOP) averaged 29.0 ± 4.2 mm Hg. Corrected visual acuity was 0.2 and higher in half of the cases. All patients used two or more antihypertensive drugs, three on average. The follow-up period after micropulse transscleral cyclophotocoagulation (mCPC) was 15 months. Results. No intraoperative complications were recorded. In the early postoperative period, complications were observed in 7.6 % of patients: short-term pain syndrome — 4.3 %, an increase in IOP above the preoperative level — 3.3 % of cases. The target IOP level was achieved in 94.7 % of cases. On average, IOP after surgery was 19.0 ± 3.5 mm Hg (p = 0.04). The number of antihypertensive drugs used decreased by 27 % (to 2.2 on average). Visual acuity remained stable in 100 % of cases, and subsequently increased in 6 patients (6.5 %), after cataract phacoemulsification with intraocular lens implantation. Conclusion. Our experience with mCFC has confirmed the effectiveness of the method in reducing and maintaining IOP at target values, as well as in reducing the number of antihypertensive drugs used. The method has proven its safety and effectiveness with a low number of complications.
- 1 October 2025
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 22 (3) , 577-581
Open AccessSurgical Treatment of Primary Open-angle Glaucoma Using Micropulse Laser Exposure
Purpose. Analysis of the results of micropulse transscleral cyclophotocoagulation in patients with primary open-angle glaucoma. Materiales and methods. The study analyzed medical records of 91 patients with primary open-angle glaucoma (POAG) stages II–IV in 93 eyes. Of these, 42 (46 %) were men and 49 (54 %) were women. The average age of the study participants was 70 ± 15 years. Stage II of the disease occurred in 28 % of cases, stage III — in 59 %, and stage IV — in 13 %. The initial intraocular pressure (IOP) averaged 29.0 ± 4.2 mm Hg. Corrected visual acuity was 0.2 and higher in half of the cases. All patients used two or more antihypertensive drugs, three on average. The follow-up period after micropulse transscleral cyclophotocoagulation (mCPC) was 15 months. Results. No intraoperative complications were recorded. In the early postoperative period, complications were observed in 7.6 % of patients: short-term pain syndrome — 4.3 %, an increase in IOP above the preoperative level — 3.3 % of cases. The target IOP level was achieved in 94.7 % of cases. On average, IOP after surgery was 19.0 ± 3.5 mm Hg (p = 0.04). The number of antihypertensive drugs used decreased by 27 % (to 2.2 on average). Visual acuity remained stable in 100 % of cases, and subsequently increased in 6 patients (6.5 %), after cataract phacoemulsification with intraocular lens implantation. Conclusion. Our experience with mCFC has confirmed the effectiveness of the method in reducing and maintaining IOP at target values, as well as in reducing the number of antihypertensive drugs used. The method has proven its safety and effectiveness with a low number of complications.
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 21 (2) , 132-136
Treatment of rhinoorbital mucoromycosis in a multimorbid patient (clinical case)
A clinical case of a rare orbital lesion with mucormycosis, which developed against the background of odontogenic osteomyelitis in a patient with diabetes mellitus, is presented. A comprehensive approach, including antifungal therapy, surgical interventions and correction of carbohydrate metabolism, made it possible to localize the infection and stabilize the patient's condition; however, vision in the right eye could not be restored.
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 21 (2) , 132-136
Treatment of rhinoorbital mucoromycosis in a multimorbid patient (clinical case)
A clinical case of a rare orbital lesion with mucormycosis, which developed against the background of odontogenic osteomyelitis in a patient with diabetes mellitus, is presented. A comprehensive approach, including antifungal therapy, surgical interventions and correction of carbohydrate metabolism, made it possible to localize the infection and stabilize the patient's condition; however, vision in the right eye could not be restored.